Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear. - Full Text View

Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.

This study has been completed.

Sponsored by:	University of Aarhus
Information provided by:	University of Aarhus
ClinicalTrials.gov Identifier:	NCT00377845

Purpose

The purpose of this study is to compare suitability, specificity and sensitivity of the routine smear and the tampon self-test women perform at home.

Study hypothesis: The tampon self-test correspond to the routine cervical smear.

Condition	Intervention	Phase
Uterine Cervical Dysplasia Uterine Cervical Neoplasms	Procedure: Regular Tampax used in 3 hours	Phase 0

MedlinePlus related topics:

Cancer Cervical Cancer

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Screening, Non-Randomized, Single Blind, Historical Control, Single Group Assignment, Efficacy Study

Official Title:	Cervix Cytological Screening - Comparison of Tampon Self-Test and the Routine Smear.

Further study details as provided by University of Aarhus:

Primary Outcome Measures:

Sensitivity and specificity of the tampon self-test

Secondary Outcome Measures:

The womens socio-demographic relations according to accept the tampon self-test

Estimated Enrollment:	100
Study Start Date:	September 2006
Study Completion Date:	March 2008
Primary Completion Date:	December 2007 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:	23 Years and older
Genders Eligible for Study:	Female
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

Women with cervical dysplasia been referred to conisation or
Women invited to cervical screening program

Exclusion Criteria:

Women not performing the tampon self-test before conisation or
Women not performing the tampon self-test af least 1 month after receiving the tampon

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00377845

Locations


Denmark
	Region Hospital Randers
	Randers, Denmark, 8900

Sponsors and Collaborators

University of Aarhus

Investigators


Study Director:	Hans Svanholm, consultant	Randers Hospital, Pathological Institute

More Information

Responsible Party:	Student ( Else Toft Würtz )
Study ID Numbers:	TP06-2351
First Received:	September 18, 2006
Last Updated:	March 26, 2008
ClinicalTrials.gov Identifier:	NCT00377845
Health Authority:	Denmark: Danish Dataprotection Agency; Denmark: Ethics Committee

Keywords provided by University of Aarhus:

self test

PAP smear

tampon test

cervical dysplasia

Study placed in the following topic categories:

Precancerous Conditions

Genital Neoplasms, Female

Uterine Diseases

Urogenital Neoplasms

Cervical Intraepithelial Neoplasia

Carcinoma

Uterine Cervical Neoplasms

Genital Diseases, Female

Uterine Cervical Diseases

Cervical intraepithelial neoplasia

Carcinoma in Situ

Uterine Neoplasms

Uterine Cervical Dysplasia

Neoplasms, Glandular and Epithelial

Additional relevant MeSH terms:

Neoplasms

Neoplasms by Histologic Type

Neoplasms by Site

ClinicalTrials.gov processed this record on August 28, 2008